Precision Health Clinical Trials
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others
Sponsor: Fudan University
Not yet recruiting
Intervention: Drug: Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others
Sponsor: Fudan University
Not yet recruiting
For more information, visit the Study URL.
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
Conditions: Toxoplasma Gondii Infection; Cancer
Interventions: Diagnostic Test: ELISA; Diagnostic Test: PCR; Diagnostic Test: Sequencing
Sponsor: Sohag University
Recruiting
Interventions: Diagnostic Test: ELISA; Diagnostic Test: PCR; Diagnostic Test: Sequencing
Sponsor: Sohag University
Recruiting
For more information, visit the Study URL.
Vascular Anomaly Pathology and Genomics Biopsy Study
Conditions: Vascular Malformations; Vascular Anomaly; Hemangioma; Arteriovenous Malformations; Venous Malformation; Klippel Trenaunay Syndrome; Lymphatic Malformation
Intervention: Procedure: Percutaneous Vascular Anomaly/Malformation Biopsy
Sponsor: Mayo Clinic
Recruiting
Intervention: Procedure: Percutaneous Vascular Anomaly/Malformation Biopsy
Sponsor: Mayo Clinic
Recruiting
For more information, visit the Study URL.
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives
Condition: Channelopathies
Intervention: Genetic: Genetic analysis
Sponsor: D'Or Institute for Research and Education
Recruiting
Intervention: Genetic: Genetic analysis
Sponsor: D'Or Institute for Research and Education
Recruiting
For more information, visit the Study URL.
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Pembrolizumab
Sponsor: Gruppo Oncologico del Nord-Ovest
Recruiting
Intervention: Drug: Pembrolizumab
Sponsor: Gruppo Oncologico del Nord-Ovest
Recruiting
For more information, visit the Study URL.
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
Condition: Primary Mediastinal Large B-cell Lymphoma
Intervention: Other: Circulating tumor DNA monitoring
Sponsor: Centre Henri Becquerel
Recruiting
Intervention: Other: Circulating tumor DNA monitoring
Sponsor: Centre Henri Becquerel
Recruiting
For more information, visit the Study URL.
Epidemiology of Gout in French Polynesia
Condition: Gout
Intervention: Other: Epidemiological study
Sponsors: Lille Catholic University; Variant Bio, Inc.; University of Birmingham; University of San Diego; Ministry of Health, French Polynesia
Not yet recruiting
Intervention: Other: Epidemiological study
Sponsors: Lille Catholic University; Variant Bio, Inc.; University of Birmingham; University of San Diego; Ministry of Health, French Polynesia
Not yet recruiting
For more information, visit the Study URL.
Epigenetics and Protective Factors in the Preterm Infant
Conditions: Preterm Birth; Parent-Child Relations; Epigenetics
Interventions: Genetic: DNA methylation of target genes; Diagnostic Test: Functional Magnetic Resonance Imaging (fMRI) acquisition
Sponsor: IRCCS Eugenio Medea
Recruiting
Interventions: Genetic: DNA methylation of target genes; Diagnostic Test: Functional Magnetic Resonance Imaging (fMRI) acquisition
Sponsor: IRCCS Eugenio Medea
Recruiting
For more information, visit the Study URL.
Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain
Conditions: Chronic Pain; Surgery
Intervention:
Sponsor: University Health Network, Toronto
Recruiting
Intervention:
Sponsor: University Health Network, Toronto
Recruiting
For more information, visit the Study URL.
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
Conditions: Malignant Pleural Effusion; Non-small Cell Lung Cancer
Intervention: Diagnostic Test: meassurement of PD-L1, ALK, EGFR
Sponsor: Naestved Hospital
Recruiting
Intervention: Diagnostic Test: meassurement of PD-L1, ALK, EGFR
Sponsor: Naestved Hospital
Recruiting
For more information, visit the Study URL.